MIR25 and gastric cancer: Mechanistically, we found that SLC34A2 could directly bind to the promoter of MIR25 and thus upregulate its level, which is consistent with the previous study showing that SLC34A could regulate miR‐25 activity to affect gastric cancer progression 19.